Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ±¸¼º ¿ä¼Òº°, ¹èÆ÷º°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)
Predictive Disease Analytics Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Service, and Hardware); By Deployment; By End-User; By Region; Segment Forecast, 2023 - 2032
»óǰÄÚµå : 1338933
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2023³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 115 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,981,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,389,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,796,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 140¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÇコÄɾîÀÇ Áúº´ ¿¹Ãø ºÐ¼®Àº ÀΰøÁö´É, µ¥ÀÌÅÍ ¸¶ÀÌ´×, Åë°è µî ´Ù¾çÇÑ ±â¼úÀ» µµÀÔÇÏ¿© Ä¡·á¸¦ Å©°Ô °³¼±ÇÏ°í °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 11¿ù Zephyr AI¿Í MedStar Health´Â ¸¸¼º Áúȯ ¿¹Ãø ºÐ¼® ´É·ÂÀ» °­È­ÇÏ´Â AI ±â¹Ý Á¦Ç°À» °³¹ßÇϱâ À§ÇØ Çù·ÂÇßÀ¸¸ç, AI¿Í ¸Ó½Å·¯´×Àº ȯÀÚ µ¥ÀÌÅ͸¦ Ç®¾î ÀÇ·á ºÐ¾ßÀÇ ´Ù¾çÇÑ º¹ÀâÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿­¼è´Ù. ±â¼úÀÇ ¹ßÀü°ú ÇÔ²² ¿¹Ãø ºÐ¼®Àº ÇコÄÉ¾î »ê¾÷ Àü¹Ý¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

º¸°ÇÀÇ·á´Â ¼ö³â µ¿¾È µðÁöÅÐÈ­µÇ¾î ȯÀÚ Ä¡·á¿Í °á°ú¿¡ Å« º¯È­¸¦ °¡Á®¿Ô½À´Ï´Ù. ÀÇ·á ±â°ü°ú ÀÇ·á ½Ã½ºÅÛÀº ºòµ¥ÀÌÅÍ Ç÷§Æû°ú AI¸¦ ¿¹Ãø ºÐ¼®¿¡ Ȱ¿ëÇÏ´Â ´Ù¾çÇÑ ¹æ¹ýÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Ææ½Çº£´Ï¾Æ ´ëÇб³ Àǰú´ëÇп¡¼­´Â ¿¹Ãø ¸ðµ¨À» ÅëÇØ ÆÐÇ÷ÁõÀÇ °ÅÀÇ 85%¸¦ ÀνÄÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ, Á¦´ë·Î ½Äº°µÇÁö ¾Ê¾Ò´ø ½ÉºÎÀü ȯÀÚÀÇ 20-30%µµ ÀνÄÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ Á¤È®µµ´Â ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ÀÇ·á ±â°üÀÌ ´Ü¼øÈ÷ ÀÌ¹Ì ¹ß»ýÇÑ °ÍÀ» ÇнÀÇÏ´Â °Í¿¡¼­ ±× µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿© ¾ÕÀ¸·Î ¹ß»ýÇÒ °ÍÀ» º¸´Ù ÀϰüµÇ°Ô ¿¹ÃøÇÏ´Â °ÍÀ¸·Î ÀüȯÇÏ´Â °ÍÀ» µ½°í ÀÖ½À´Ï´Ù.

Á¤ºÎÀÇ Áö¿øÀº ¼¼°è ¼öÀÍ Çâ»ó¿¡ Å« ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¼¼°è ¿©·¯ ±¹°¡ÀÇ Á¤ºÎ´Â Áúº´ ¿¹Ãø ºÐ¼®¿¡ ¼ö¹é¸¸ ´Þ·¯¸¦ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ Á¤ºÎ´Â 2023³â 3¿ù ÀΰøÁö´É(AI)À» Ȱ¿ëÇØ ȯÀÚ Áø´ÜÀ» °­È­Çϱâ À§ÇØ ÀÌ ºÐ¾ßÀÇ ÃÖÀü¼±¿¡ ÀÖ´Â ±â¾÷¿¡ 1,690¸¸ ´Þ·¯ ÀÌ»óÀ» Áö¿øÇßÀ¸¸ç, 3Â÷·Ê¿¡ °ÉÃÄ ÃÑ 1¾ï 3,000¸¸ ´Þ·¯°¡ 86°³ÀÇ AI ¼Ö·ç¼Ç¿¡ ÅõÀԵǾî 30¸¸ ¸í ÀÌ»óÀÇ È¯ÀÚ¸¦ Áö¿øÇß´Ù, ¾Ï, ½ÉÀ庴, ´ç´¢º´, Á¤½ÅÁúȯ, ½Å°æÁúȯ µî Áúº´ Ä¡·á¿Í °ü¸®¸¦ °­È­Çß½À´Ï´Ù. ÀÌ ¿äÀÎÀº ¼¼°èÀûÀ¸·Î ½ÃÀå ¼öÀÍÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¼¼°èÀûÀ¸·Î µðÁöÅÐÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó 2022³â¿¡´Â ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß°¡ ¼¼°è ½ÃÀå Á¡À¯À²À» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ŭ¶ó¿ìµå ±â¹Ý ºÎ¹®Àº »ç¿ëÀÚ Âü¿©°¡ Å©°Ô È®´ëµÇ°í È¿À²¼º°ú À¯¿¬¼ºÀÌ Çâ»óµÇ¸é¼­ °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2022³â ¼¼°è ½ÃÀå Á¡À¯À²Àº ÇコÄɾî ÁöºÒÀÚ ºÎ¹®ÀÌ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¸¹Àº ÁöºÒÀÚ »çÀÌ¿¡¼­ Áúº´ ¿¹Ãø ºÐ¼® µµ±¸ÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

ºÏ¹Ì°¡ 2022³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ÀÌ Áö¿ª¿¡ ¿©·¯ ½ÃÀå ¸®´õ°¡ Á¸ÀçÇϰí, ¸¸¼ºÁúȯ ȯÀÚ°¡ Áõ°¡Çϰí, ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

¼¼°è Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå¿¡´Â ¿À¶óŬ, IBM, SAS, ¿Ã½ºÅ©¸³Æ® ÇコÄÉ¾î ¼Ö·ç¼ÇÁî, MedeAnalytics, Health Catalyst, Apixio µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå, ÄÄÆ÷³ÍÆ®º°

Á¦6Àå ¼¼°èÀÇ Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå, Àü°³ Çüź°

Á¦7Àå ¼¼°èÀÇ Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°

Á¦8Àå ¼¼°èÀÇ Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå, Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global predictive disease analytics market size is expected to reach USD 14.04 billion by 2032, according to a new study by Polaris Market Research. The report "Predictive Disease Analytics Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Service, and Hardware); By Deployment; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Predictive disease analytics in healthcare has significantly improved care and enhanced outcomes by implementing various technologies such as artificial intelligence, data mining, statistics, etc. For instance, in November 2022, Zephyr AI & MedStar Health partnered to develop their AI-based product, which enhances predictive analytical capabilities for chronic diseases. AI & machine learning are keys to unlocking patient data and solving various complex problems in healthcare. With technological development, predictive analytics have tremendously impacted the overall healthcare industry.

Healthcare has been digitized for many years, creating massive patient care and outcomes changes. Providers and health systems are exploring diverse methods to use big data platforms and AI for predictive analytics. For example, Penn Medicine observed that the predictive model could recognize almost 85% of sepsis cases. It also recognized between 20 and 30% of heart failure patients who had not been appropriately identified. The accuracy of these solutions is largely improving the demand for analytics. These solutions are assisting health organizations in transitioning from merely learning what has already occurred to using that data to more consistently forecast what will occur.

Government support is playing a huge role in helping to improve global revenue. The governments of several countries worldwide are investing millions of dollars in predictive disease analytics. For example, in March 2023, the UK government committed over US$ 16.9 million to businesses at the forefront of this field in an effort to employ artificial intelligence (AI) to enhance patient diagnostics. Over three rounds of awards, US$ 130 million has been spent on 86 AI solutions, assisting over 300,000 patients and enhancing their care and treatment for illnesses like cancer, heart disease, diabetes, mental illness, and neurological disorders. This factor is boosting the market's revenue globally.

Predictive Disease Analytics Market Report Highlights

Software segment is expected to lead the global market share in 2022 primarily due to growing digitalization across the globe

Cloud-based segment is expected to grow with the fastest CAGR due to largely expanding user engagement, improved efficiency, and flexibility

Healthcare payer segment was dominating the global market share in 2022. This is attributed to the growing adoption of predictive disease analytics tools among many payers

North America held the largest share in 2022 due to the presence of several market leaders in the region, increasing cases of chronic diseases, and growing healthcare expenditure

The global predictive disease analytics market involves Oracle, IBM, SAS, Allscripts Healthcare Solutions, MedeAnalytics, Health Catalyst, and Apixio.

Polaris Market Research has segmented the predictive disease analytics market report based on component, deployment, end-user, and region:

Predictive Disease Analytics, Component Outlook (Revenue - USD Billion, 2019 - 2032)

Predictive Disease Analytics, Deployment Outlook (Revenue - USD Billion, 2019 - 2032)

Predictive Disease Analytics, End User Outlook (Revenue - USD Billion, 2019 - 2032)

Predictive Disease Analytics, Regional Outlook (Revenue - USD Billion, 2019-2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Predictive Disease Analytics Market Insights

5. Global Predictive Disease Analytics Market, by Component

6. Global Predictive Disease Analytics Market, by Deployment

7. Global Predictive Disease Analytics Market, by End-User

8. Global Predictive Disease Analytics Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â